Association between baseline Natriuretic peptides and Atrial fibrillation recurrence after catheter ablation a meta-analysis

International Heart Journal

Volumn 57, Issue 2, 2016, Pages 183-189

  Zhang, Yunhe ^a   Chen, Ao ^a   Song, Lei ^a   Li, Min ^a   Chen, Yingmin ^a   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

BNP; NT pro BNP; Predictive

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; BIOLOGICAL MARKER;

ABLATION THERAPY; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR PARAMETERS; CATHETER ABLATION; COMPLEX FRACTIONATED ATRIAL ELECTROGRAPHY; FOLLOW UP; HUMAN; LINEAR ABLATION; META ANALYSIS; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SINUS RHYTHM; BLOOD; PROGNOSIS;

ATRIAL FIBRILLATION; BIOMARKERS; CATHETER ABLATION; HUMANS; NATRIURETIC PEPTIDES; PROGNOSIS;

EID: 84961658263     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.15-355     Document Type: Article

References (40)

1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129: 837-47.
2. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130: 2071-104.
3. Haegeli LM, Calkins H. Catheter ablation of atrial fibrillation: an update. Eur Heart J 2014; 35: 2454-9. (Review)
4. Volpe M, Rubattu S, Burnett J Jr. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J 2014; 35: 419-25. (Review)
5. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004; 93: 1555-8.
6. Knudsen CW, Omland T, Clopton P, et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 2005; 46: 838-44.
7. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005; 45: 82-6.
8. Pillarisetti J, Reddy N, Biria M, et al. Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time? J Interv Card Electrophysiol 2014; 40: 161-8.
9. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12. (Review)
10. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: http://www.cochranehandbook. org. Accessed August 16, 2015.
11. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/nosgen.pdf. Accessed August 16, 2015.
12. Date T, Yamane T, Inada K, et al. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. Heart 2006; 92: 1623-7.
13. Yamada T, Murakami Y, Okada T, et al. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation. Am J Cardiol 2006; 97: 1741-4.
14. Nakazawa Y, Ashihara T, Tsutamoto T, Ito M, Horie M. Endothelin- 1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation. Heart Rhythm 2009; 6: 725-30.
15. Degener S, Pattberg SV, Feuersenger H, et al. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation. J Interv Card Electrophysiol 2011; 30: 217-25.
16. Machino-Ohtsuka T, Seo Y, Tada H, et al. Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 999-1006.
17. Naruse Y, Tada H, Sekiguchi Y, et al. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm 2011; 8: 335-41.
18. Okumura Y, Watanabe I, Nakai T, et al. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase- 2 as a predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol 2011; 22: 987-93.
19. Im SI, Shin SY, Na JO, et al. Usefulness of neutrophil/lymphocyte ratio in predicting early recurrence after radiofrequency catheter ablation in patients with atrial fibrillation. Int J Cardiol 2013; 168: 4398-400.
20. Kimura T, Takatsuki S, Inagawa K, et al. Serum inflammation markers predicting successful initial catheter ablation for atrial fibrillation. Heart Lung Circ 2014; 23: 636-43.
21. Nilsson B, Goetze JP, Chen X, Pehrson S, Svendsen JH. Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation. Scand J Clin Lab Invest 2009; 69: 843-50.
22. Hwang HJ, Son JW, Nam BH, et al. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation. Clin Res Cardiol 2009; 98: 213-8.
23. den Uijl DW, Delgado V, Tops LF, et al. Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation. Am Heart J 2011; 161: 197-203.
24. Fan J, Cao H, Su L, et al. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation. J Interv Card Electrophysiol 2012; 33: 93-100.
25. Fiala M, Wichterle D, Bulkova V, et al. A prospective evaluation of haemodynamics, functional status, and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation. Europace 2014; 16: 15-25.
26. Sasaki N, Okumura Y, Watanabe I, et al. Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation. J Interv Card Electrophysiol 2014; 39: 241-9.
27. Giannopoulos G, Kossyvakis C, Angelidis C, et al. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation. Heart Rhythm 2015; 12: 1470-5.
28. Parwani AS, von Haehling S, Kolodziejski AI, et al. Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2015; 180: 129-33.
29. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
30. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-52.
31. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003; 107: 2920-5.
32. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-66.
33. Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med 2008; 168: 581-6. (Review)
34. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009; 2: 349-61. (Review)
35. Cai L, Yin Y, Ling Z, et al. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2013; 164: 82-7.
36. Evranos B, Aytemir K, Oto A, et al. Predictors of atrial fibrillation recurrence after atrial fibrillation ablation with cryoballoon. Cardiol J 2013; 20: 294-303.
37. Mulder AA, Wijffels MC, Wever EF, Boersma LV. Early recur rence of atrial fibrillation as a predictor for 1-year efficacy after successful phased RF pulmonary vein isolation: evaluation of complaints and multiple Holter recordings. Int J Cardiol 2013; 165: 56-60.
38. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357-68. (Review)
39. Hussein AA, Saliba WI, Martin DO, et al. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation. Circulation 2011; 123: 2077-82.
40. Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y, Furukawa TA. Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol 2014; 14: 30.